NCT01853930

Brief Summary

Age-related macular degeneration (AMD) is the most common visual impairment in persons over 50 years of age. It has been estimated that 1 in 3 individuals over 75 years of age and 1 in 30 individuals over 52 years of age are affected by AMD. The deficits in visual function as a result of this disease affecting the central retina are debilitating, as individuals lose their ability to carry out many of their daily activities that require resolving fine spatial details. The investigator's previous studies have shown that training with oculomotor control exercises significantly increases reading speeds in patients with AMD. In the proposed study, the investigators will examine whether these training exercises are effective when practiced at home. In Phase 1, the investigators will develop a standardized user-friendly, Web-based platform that will allow patients to easily self-administer training exercises. The software platform will be designed to automatically choose the appropriate exercises based on a patient's previous performance, run the training exercise, and collect performance data into a universal patient data file. In Phase 2, the platform will be tested in two settings: in standard clinical rehabilitation practice and in the patient's home. Reading outcomes in the two settings will be compared. The investigators will recruit 60 patients per year for each of the three years for Phase 2 of the study. Half of these patients will be assigned to the Clinic Training Group, while the other half will be assigned to At-home Training Group. For all patients, three assessments will be taken: at baseline, after 1 month, and after 2 months of training. The investigators will compare reading outcomes to assess the roles of feedback versus the role of frequent available practice. Because of the extensive cost and clinical resources required for vision rehabilitation, it is critical to determine whether the training program can be made less expensive, but as effective, when it is self-trained. If the investigators demonstrate the utility of at-home practice, clinical facilities and therapists' time can be made available for those activities requiring face-to-face contact

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2013

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 15, 2013

Completed
8 months until next milestone

Study Start

First participant enrolled

January 1, 2014

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2017

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

November 13, 2019

Completed
Last Updated

November 13, 2019

Status Verified

October 1, 2019

Enrollment Period

3.5 years

First QC Date

May 2, 2013

Results QC Date

November 16, 2018

Last Update Submit

October 23, 2019

Conditions

Keywords

reading rehabilitationmacular degenerationeccentric viewing

Outcome Measures

Primary Outcomes (1)

  • Change in Reading Performance and Accuracy Using MNREAD.

    Participants will be trained to use eccentric viewing for reading. They will then be assessed on the following outcome measures; reading, speed and accuracy using the MNRead test, binocular visual acuity and contrast sensitivity.

    Participants will be assessed at baseline, 1 month and 2 months but change between baseline and final (2 months) will be reported

Study Arms (2)

Laboratory training

OTHER

Patients will be trained in the laboratory with feedback by a rehabilitation therapist

Behavioral: Platform for Administering Eye-movement Control Training

Home-based training

OTHER

Patients will self instruct using the computer-based training with remote intervention by a therapist

Behavioral: Platform for Administering Eye-movement Control Training

Interventions

The Platform for Administering Eye-movement Control Training (PAECT) meta program will incorporate all of the exercises that the investigators have developed and validated over the course of our previous Merit Review grants (Seiple, Szlyk et al., 2005, 2011). The PAECT platform will be designed to allow patients to easily run the training exercises in their homes and to practice at their convenience. The PAECT will employ an executive component that will keep track of the exercises that are practiced and record performance. Each time a subject opens the platform, it will choose the exercise for that subject based upon previous training and performance.

Home-based trainingLaboratory training

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a diagnosis of retinal disease affecting the central visual field (e.g., non-exudative "dry" AMD)
  • with a central scotoma
  • and with visual acuity of less than or equal to 20/70 and greater than or equal to 20/400 (in the test eye), will be included in the study.
  • The presence of a central scotoma and eccentric viewing will be confirmed using an OPKO OCT/SLO microperimetry.
  • The investigator's intent is to include subjects based upon the patient's functional characteristics (e.g., eccentric viewing).

You may not qualify if:

  • Patients with other major ophthalmologic or neurologic disease
  • choroidal neovascularization ("wet" AMD)
  • moderate to severe media opacities
  • and cognitive impairment will be excluded.
  • Patients' disease status will be monitored throughout the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jesse Brown VA Medical Center, Chicago, IL

Chicago, Illinois, 60612, United States

Location

Related Publications (6)

  • Ming J, Thulborn KR, Szlyk JP. Reproducibility of activation maps for longitudinal studies of visual function by functional magnetic resonance imaging. Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6153-63. doi: 10.1167/iovs.11-8375.

  • Grant P, Seiple W, Szlyk JP. Effect of depression on actual and perceived effects of reading rehabilitation for people with central vision loss. J Rehabil Res Dev. 2011;48(9):1101-8. doi: 10.1682/jrrd.2010.05.0080.

  • Seiple W, Grant P, Szlyk JP. Reading rehabilitation of individuals with AMD: relative effectiveness of training approaches. Invest Ophthalmol Vis Sci. 2011 May 5;52(6):2938-44. doi: 10.1167/iovs.10-6137.

  • Szlyk JP, Little DM. An FMRI study of word-level recognition and processing in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4487-95. doi: 10.1167/iovs.08-2258. Epub 2009 Apr 22.

  • Soong GP, Shapiro M, Seiple W, Szlyk JP. Macular structure and vision of patients with macular heterotopia secondary to retinopathy of prematurity. Retina. 2008 Oct;28(8):1111-6. doi: 10.1097/IAE.0b013e3181744136.

  • Little DM, Thulborn KR, Szlyk JP. An FMRI study of saccadic and smooth-pursuit eye movement control in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1728-35. doi: 10.1167/iovs.07-0372.

MeSH Terms

Conditions

Macular Degeneration

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal DiseasesEye Diseases

Limitations and Caveats

Future research will address some of the limitations of this study such as greater diversity of subjects, a larger sample size and additional development and refinement of the program interface and user experience.

Results Point of Contact

Title
Dr. Janet P. Szlyk, PhD
Organization
Jesse Brown VA Medical Center

Study Officials

  • Janet P Szlyk, PhD

    Jesse Brown VA Medical Center, Chicago, IL

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2013

First Posted

May 15, 2013

Study Start

January 1, 2014

Primary Completion

June 30, 2017

Study Completion

June 30, 2017

Last Updated

November 13, 2019

Results First Posted

November 13, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations